American Academy of Allergy, Asthma and Immunology Annual Meeting

American Academy of Allergy, Asthma and Immunology Annual Meeting

March 09, 2016
1 min read

Guidelines needed for physicians treating venom allergy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

LOS ANGELES — A need for physician education is prompted by the remarkably low percentage of patients with systematic reactions to venom stings who saw an allergist and were prescribed self-injectable epinephrine, according to recent study findings presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

“According to the latest practice parameter, referral to an allergist is appropriate for any patient who has had an allergic reaction to hymenoptera and is a potential candidate for immunotherapy,” researcher Priya J. Patel, MD, of Rutgers New Jersey Medical School, and colleagues wrote. “As a quality control measure, we determined whether physicians at our hospital followed this recommendation.”

Patel and colleagues examined 620 patients with a documented history of insect allergy, noting whether their reactions were systemic, local or unclear. Of those with systemic reactions, investigators determined whether or not epinephrine was prescribed for self-injection.

Results of the study showed that 61% of patients had a systemic reaction, 6% had a local reaction, and 33% were unclear. Fifty-three percent of those identified as having a systemic reaction were prescribed epinephrine; however, the prescription was expired in 67%. Only 12% of the patients with a systemic reaction acquired an allergy and immunology consultation.

“It is important to educate physicians to prescribe self-injectable epinephrine and refer to an allergist when a systemic reaction to venom allergy is identified,” the researchers wrote. – by Alaina Tedesco

Reference: Patel PJ, et al. Abstract 154. Presented at: American Academy of Allergy, Asthma & Immunology Annual Meeting; March 4-7, 2016; Los Angeles.

Disclosure: was unable to confirm relevant financial disclosures at the time of reporting.